This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Tama Evron, Ph.D
Director, Platform Discovery at Dyne Therapeutics
Speaker

Profile

Tama Evron is an established pharmacologist with strong experience in drug discovery across a wide range of indications and therapeutics modalities, including small molecules and biologics. Tama is currently Director, Platform Discovery at Dyne Therapeutics where she leads platform expansion projects focused on receptor-mediated delivery of oligonucleotides for the treatment of genetic muscle diseases. Prior to joining Dyne, Tama served in leading roles of increasing responsibilities at several biotechnology companies where she managed drug discovery projects, from target identification to candidate selection and early development. Tama received her doctorate in biochemistry from the Hebrew University of Jerusalem followed by postdoctoral fellowship training in GPCR molecular pharmacology at Duke University

Agenda Sessions

  • The FORCE Platform Leverages TfR1 for Delivery of Potentially Disease-modifying Therapeutics to Treat Muscle Diseases

    3:30pm